Considering the differences in the pathological process of CAVD between female and male patients, including a higher fibrotic burden in female patients relative to their male counterparts, PAR2 protein expression were examined in female patient-derived hVICs33. This evidence concerns the gene F2RL1 and congenital bilateral aplasia of vas deferens from CFTR mutation.